• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三氧化二砷联合细胞毒性T细胞在结肠癌肺转移模型中的协同抗肿瘤作用

The synergistic antitumor effect of arsenic trioxide combined with cytotoxic T cells in pulmonary metastasis model of colon cancer.

作者信息

Wang Lei, Liang Wentao, Peng Na, Hu Xiang, Xu Yingxin, Liu Zhong

机构信息

Department of General Surgery, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.

The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China.

出版信息

Oncotarget. 2017 Nov 30;8(65):109609-109618. doi: 10.18632/oncotarget.22757. eCollection 2017 Dec 12.

DOI:10.18632/oncotarget.22757
PMID:29312633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5752546/
Abstract

Adoptive T cell therapy, including cytotoxic T lymphocytes (CTLs), represents a promising non-toxic anticancer strategy. The effects of this therapy can be impaired by tumor-infiltrated regulatory T cells (Tregs). Autologous murine CTLs acquired using cryopreservation exhibited a cytotoxic effect equivalent to that of conventional CTLs. The killing activity of CTLs was enhanced significantly using arsenic trioxide (ATO), accompanied by reduction in Tregs . Results using a pulmonary metastasis model of colon cancer indicated that compared with the control group, ATO group, and CTLs group, metastatic node number decreased significantly (<0.001, <0.001, <0.001, respectively) and survival time was prolonged (<0.001, =0.669, =0.158, respectively) in the ATO plus CTLs group. The number of infiltrated Foxp3+ Tregs decreased in the tumor center, but increased in the peri-tumor tissue. Our results indicate that this approach represents a practical protocol for acquiring autologous CTLs and a feasible strategy that uses a synergistic combination of ATO plus CTLs to treat pulmonary metastases of colon cancer.

摘要

过继性T细胞疗法,包括细胞毒性T淋巴细胞(CTL),是一种很有前景的无毒抗癌策略。肿瘤浸润调节性T细胞(Treg)会削弱这种疗法的效果。使用冷冻保存获得的自体小鼠CTL表现出与传统CTL相当的细胞毒性作用。使用三氧化二砷(ATO)可显著增强CTL的杀伤活性,并伴有Treg数量减少。使用结肠癌肺转移模型的结果表明,与对照组、ATO组和CTL组相比,ATO加CTL组的转移结节数量显著减少(分别为<0.001、<0.001、<0.001),生存时间延长(分别为<0.001、=0.669、=0.158)。肿瘤中心浸润的Foxp3 + Treg数量减少,但肿瘤周围组织中的数量增加。我们的结果表明,这种方法是获取自体CTL的实用方案,也是使用ATO加CTL协同组合治疗结肠癌肺转移的可行策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4838/5752546/4c41fed0f56c/oncotarget-08-109609-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4838/5752546/09c0fccb0137/oncotarget-08-109609-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4838/5752546/c1f2e78d8fa9/oncotarget-08-109609-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4838/5752546/63b6ba879d3a/oncotarget-08-109609-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4838/5752546/9063d999bf95/oncotarget-08-109609-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4838/5752546/8756e980a4f3/oncotarget-08-109609-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4838/5752546/4c41fed0f56c/oncotarget-08-109609-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4838/5752546/09c0fccb0137/oncotarget-08-109609-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4838/5752546/c1f2e78d8fa9/oncotarget-08-109609-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4838/5752546/63b6ba879d3a/oncotarget-08-109609-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4838/5752546/9063d999bf95/oncotarget-08-109609-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4838/5752546/8756e980a4f3/oncotarget-08-109609-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4838/5752546/4c41fed0f56c/oncotarget-08-109609-g006.jpg

相似文献

1
The synergistic antitumor effect of arsenic trioxide combined with cytotoxic T cells in pulmonary metastasis model of colon cancer.三氧化二砷联合细胞毒性T细胞在结肠癌肺转移模型中的协同抗肿瘤作用
Oncotarget. 2017 Nov 30;8(65):109609-109618. doi: 10.18632/oncotarget.22757. eCollection 2017 Dec 12.
2
Arsenic trioxide inhibits lung metastasis of mouse colon cancer via reducing the infiltration of regulatory T cells.三氧化二砷通过减少调节性T细胞的浸润来抑制小鼠结肠癌的肺转移。
Tumour Biol. 2016 Nov;37(11):15165-15173. doi: 10.1007/s13277-016-5377-3. Epub 2016 Sep 27.
3
Immunosuppressive effect of regulatory T lymphocytes in lung cancer, with special reference to their effects on the induction of autologous tumor-specific cytotoxic T lymphocytes.调节性T淋巴细胞在肺癌中的免疫抑制作用,特别提及它们对诱导自体肿瘤特异性细胞毒性T淋巴细胞的影响。
Oncol Lett. 2012 Oct;4(4):625-630. doi: 10.3892/ol.2012.815. Epub 2012 Jul 20.
4
[Acquirement of autologous murine cytotoxic T lymphocytes via cryopreservation of lymphocytes].通过淋巴细胞冷冻保存获取自体小鼠细胞毒性T淋巴细胞
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Nov;32(11):1453-1457.
5
OCT4&SOX2-specific cytotoxic T lymphocytes plus programmed cell death protein 1 inhibitor presented with synergistic effect on killing lung cancer stem-like cells in vitro and treating drug-resistant lung cancer mice in vivo.OCT4 和 SOX2 特异性细胞毒性 T 淋巴细胞加程序性细胞死亡蛋白 1 抑制剂在体外杀伤肺癌干细胞样细胞和体内治疗耐药性肺癌小鼠方面表现出协同作用。
J Cell Physiol. 2019 May;234(5):6758-6768. doi: 10.1002/jcp.27423. Epub 2018 Nov 1.
6
Effect of arsenic trioxide on the Tregs ratio and the levels of IFN-γ, IL-4, IL-17 and TGF-β1 in the peripheral blood of severe aplastic anemia patients.三氧化二砷对重型再生障碍性贫血患者外周血中调节性T细胞比例及干扰素-γ、白细胞介素-4、白细胞介素-17和转化生长因子-β1水平的影响
Medicine (Baltimore). 2020 Jun 26;99(26):e20630. doi: 10.1097/MD.0000000000020630.
7
CD8 cytotoxic T lymphocytes in cancer immunotherapy: A review.癌症免疫治疗中的 CD8 细胞毒性 T 淋巴细胞:综述。
J Cell Physiol. 2019 Jun;234(6):8509-8521. doi: 10.1002/jcp.27782. Epub 2018 Nov 22.
8
CD40 monoclonal antibody and OK432 synergistically promote the activation of dendritic cells in immunotherapy.CD40单克隆抗体与OK432在免疫治疗中协同促进树突状细胞的活化。
Cancer Cell Int. 2022 Jun 17;22(1):216. doi: 10.1186/s12935-022-02630-x.
9
Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection.肿瘤内调节性 T 细胞单独或与细胞毒性 T 细胞联合预测肝癌切除术后的预后。
Med Oncol. 2012 Sep;29(3):1817-26. doi: 10.1007/s12032-011-0006-x. Epub 2011 Jun 16.
10
Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphoma.白细胞介素 15 为 CTL 提供了免于调节性 T 细胞介导抑制的保护:对基于过继性 T 细胞治疗淋巴瘤的启示。
Clin Cancer Res. 2013 Jan 1;19(1):106-17. doi: 10.1158/1078-0432.CCR-12-2143. Epub 2012 Nov 13.

引用本文的文献

1
CD40 monoclonal antibody and OK432 synergistically promote the activation of dendritic cells in immunotherapy.CD40单克隆抗体与OK432在免疫治疗中协同促进树突状细胞的活化。
Cancer Cell Int. 2022 Jun 17;22(1):216. doi: 10.1186/s12935-022-02630-x.
2
Arsenic trioxide (ATO) induced degradation of Cyclin D1 sensitized PD-1/PD-L1 checkpoint inhibitor in oral and esophageal squamous cell carcinoma.三氧化二砷(ATO)诱导细胞周期蛋白D1降解,使口腔和食管鳞状细胞癌对PD-1/PD-L1检查点抑制剂敏感。
J Cancer. 2020 Sep 21;11(22):6516-6529. doi: 10.7150/jca.47111. eCollection 2020.

本文引用的文献

1
Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response.直肠癌新辅助放化疗前肿瘤浸润调节性T细胞密度不能预测治疗反应。
Oncotarget. 2017 Mar 21;8(12):19803-19813. doi: 10.18632/oncotarget.15048.
2
Arsenic trioxide is an immune adjuvant in liver cancer treatment.三氧化二砷在肝癌治疗中是一种免疫佐剂。
Mol Immunol. 2017 Jan;81:118-126. doi: 10.1016/j.molimm.2016.12.001. Epub 2016 Dec 7.
3
[Acquirement of autologous murine cytotoxic T lymphocytes via cryopreservation of lymphocytes].
通过淋巴细胞冷冻保存获取自体小鼠细胞毒性T淋巴细胞
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Nov;32(11):1453-1457.
4
Arsenic trioxide inhibits lung metastasis of mouse colon cancer via reducing the infiltration of regulatory T cells.三氧化二砷通过减少调节性T细胞的浸润来抑制小鼠结肠癌的肺转移。
Tumour Biol. 2016 Nov;37(11):15165-15173. doi: 10.1007/s13277-016-5377-3. Epub 2016 Sep 27.
5
The prognostic value of FOXP3+ T regulatory cells in colorectal cancer.FOXP3 + T调节性细胞在结直肠癌中的预后价值。
J BUON. 2015 Jan-Feb;20(1):114-9.
6
Using chemo-drugs or irradiation to break immune tolerance and facilitate immunotherapy in solid cancer.使用化疗药物或放疗来打破免疫耐受并促进实体癌的免疫治疗。
Cell Immunol. 2015 Mar;294(1):54-9. doi: 10.1016/j.cellimm.2015.02.003. Epub 2015 Feb 10.
7
Combined therapy with CTL cells and oncolytic adenovirus expressing IL-15-induced enhanced antitumor activity.细胞毒性T淋巴细胞(CTL)与表达白细胞介素-15的溶瘤腺病毒联合治疗可增强抗肿瘤活性。
Tumour Biol. 2015 Jun;36(6):4535-43. doi: 10.1007/s13277-015-3098-7. Epub 2015 Jan 28.
8
PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.聚腺苷二磷酸核糖聚合酶-1 抑制剂通过消除 G2/M 检查点和抑制 DNA 损伤修复使三氧化二砷在肝癌细胞中敏感化。
Chem Biol Interact. 2015 Jan 25;226:12-22. doi: 10.1016/j.cbi.2014.12.007. Epub 2014 Dec 11.
9
Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation.三氧化二砷通过抑制Akt激活增强索拉非尼对肝细胞癌的抗癌活性。
Tumour Biol. 2015 Apr;36(4):2323-34. doi: 10.1007/s13277-014-2839-3. Epub 2014 Nov 22.
10
T-cell-associated cellular immunotherapy for lung cancer.用于肺癌的T细胞相关细胞免疫疗法。
J Cancer Res Clin Oncol. 2015 Jul;141(7):1249-58. doi: 10.1007/s00432-014-1867-0. Epub 2014 Nov 8.